MINERALYS THERAPEUTICS INC (MLYS) — insider trading
Health Care · NASDAQ
MINERALYS THERAPEUTICS INC (MLYS) has 54 reported SEC Form 4 insider transactions in our data, including 18 open-market sales among the most recent 54 (latest 2026-07-17).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-17 | Rodman David Malcom | Officer (Chief Medical Officer) | Option exercise / conversion (derivative) | 416 | $0.00 | $0 | Form 4 |
| 2026-07-17 | Rodman David Malcom | Officer (Chief Medical Officer) | Open-market sale | 416 | $26.53 | $11.0K | Form 4 |
| 2026-07-17 | Rodman David Malcom | Officer (Chief Medical Officer) | Option exercise / conversion | 416 | $15.44 | $6.4K | Form 4 |
| 2026-07-15 | Rodman David Malcom | Officer (Chief Medical Officer) | Open-market sale | 6,349 | $26.61 | $169.0K | Form 4 |
| 2026-07-13 | Rodman David Malcom | Officer (Chief Medical Officer) | Option exercise / conversion (derivative) | 6,349 | $0.00 | $0 | Form 4 |
| 2026-07-13 | Rodman David Malcom | Officer (Chief Medical Officer) | Option exercise / conversion (derivative) | 4,167 | $0.00 | $0 | Form 4 |
| 2026-07-13 | Rodman David Malcom | Officer (Chief Medical Officer) | Option exercise / conversion (derivative) | 3,542 | $0.00 | $0 | Form 4 |
| 2026-07-13 | Rodman David Malcom | Officer (Chief Medical Officer) | Open-market sale | 14,058 | $27.58 | $387.7K | Form 4 |
| 2026-07-13 | Rodman David Malcom | Officer (Chief Medical Officer) | Option exercise / conversion | 6,349 | $1.08 | $6.9K | Form 4 |
| 2026-07-13 | Rodman David Malcom | Officer (Chief Medical Officer) | Option exercise / conversion | 4,167 | $14.25 | $59.4K | Form 4 |
| 2026-07-13 | Rodman David Malcom | Officer (Chief Medical Officer) | Option exercise / conversion | 3,542 | $10.20 | $36.1K | Form 4 |
| 2026-07-13 | Congleton Jon | Director, Officer (Chief Executive Officer) | Open-market sale | 10,700 | $27.24 | $291.4K | Form 4 |
| 2026-07-09 | Rodman David Malcom | Officer (Chief Medical Officer) | Option exercise / conversion (derivative) | 2,171 | $0.00 | $0 | Form 4 |
| 2026-07-09 | Rodman David Malcom | Officer (Chief Medical Officer) | Open-market sale | 2,171 | $30.30 | $65.8K | Form 4 |
| 2026-07-09 | Rodman David Malcom | Officer (Chief Medical Officer) | Option exercise / conversion | 2,171 | $16.00 | $34.7K | Form 4 |
| 2026-06-30 | Congleton Jon | Director, Officer (Chief Executive Officer) | Open-market sale | 17,000 | $26.82 | $455.9K | Form 4 |
| 2026-06-30 | Congleton Jon | Director, Officer (Chief Executive Officer) | Open-market sale | 58,000 | $25.94 | $1.50M | Form 4 |
| 2026-06-26 | Warren Eric | Officer (Chief Commercial Officer) | Option exercise / conversion (derivative) | 104,124 | $0.00 | $0 | Form 4 |
| 2026-06-26 | Warren Eric | Officer (Chief Commercial Officer) | Open-market sale | 104,124 | $25.90 | $2.70M | Form 4 |
| 2026-06-26 | Warren Eric | Officer (Chief Commercial Officer) | Option exercise / conversion | 104,124 | $13.24 | $1.38M | Form 4 |
| 2026-06-17 | Karydas Daphne | Director | Option exercise / conversion (derivative) | 3,000 | $0.00 | $0 | Form 4 |
| 2026-06-17 | Karydas Daphne | Director | Open-market sale | 3,000 | $25.00 | $75.0K | Form 4 |
| 2026-06-17 | Karydas Daphne | Director | Option exercise / conversion | 3,000 | $12.02 | $36.1K | Form 4 |
| 2026-06-17 | Rodman David Malcom | Officer (Chief Medical Officer) | Option exercise / conversion (derivative) | 417 | $0.00 | $0 | Form 4 |
| 2026-06-17 | Rodman David Malcom | Officer (Chief Medical Officer) | Option exercise / conversion (derivative) | 4,167 | $0.00 | $0 | Form 4 |
| 2026-06-17 | Rodman David Malcom | Officer (Chief Medical Officer) | Open-market sale | 4,584 | $25.00 | $114.6K | Form 4 |
| 2026-06-17 | Rodman David Malcom | Officer (Chief Medical Officer) | Option exercise / conversion | 417 | $15.44 | $6.4K | Form 4 |
| 2026-06-17 | Rodman David Malcom | Officer (Chief Medical Officer) | Option exercise / conversion | 4,167 | $14.25 | $59.4K | Form 4 |
| 2026-06-15 | Rodman David Malcom | Officer (Chief Medical Officer) | Option exercise / conversion (derivative) | 3,542 | $0.00 | $0 | Form 4 |
| 2026-06-15 | Rodman David Malcom | Officer (Chief Medical Officer) | Open-market sale | 9,890 | $23.81 | $235.5K | Form 4 |
| 2026-06-15 | Rodman David Malcom | Officer (Chief Medical Officer) | Option exercise / conversion | 3,542 | $10.20 | $36.1K | Form 4 |
| 2026-06-12 | Rodman David Malcom | Officer (Chief Medical Officer) | Option exercise / conversion (derivative) | 6,349 | $0.00 | $0 | Form 4 |
| 2026-06-12 | Rodman David Malcom | Officer (Chief Medical Officer) | Open-market sale | 6,349 | $23.93 | $151.9K | Form 4 |
| 2026-06-12 | Rodman David Malcom | Officer (Chief Medical Officer) | Option exercise / conversion | 6,349 | $1.08 | $6.9K | Form 4 |
| 2026-06-10 | Rodman David Malcom | Officer (Chief Medical Officer) | Option exercise / conversion (derivative) | 2,170 | $0.00 | $0 | Form 4 |
| 2026-06-10 | Rodman David Malcom | Officer (Chief Medical Officer) | Open-market sale | 2,170 | $25.00 | $54.3K | Form 4 |
| 2026-06-10 | Rodman David Malcom | Officer (Chief Medical Officer) | Option exercise / conversion | 2,170 | $16.00 | $34.7K | Form 4 |
| 2026-05-18 | Rodman David Malcom | Officer (Chief Medical Officer) | Option exercise / conversion (derivative) | 417 | $0.00 | $0 | Form 4 |
| 2026-05-18 | Rodman David Malcom | Officer (Chief Medical Officer) | Open-market sale | 417 | $27.55 | $11.5K | Form 4 |
| 2026-05-18 | Rodman David Malcom | Officer (Chief Medical Officer) | Option exercise / conversion | 417 | $15.44 | $6.4K | Form 4 |
| 2026-05-13 | Rodman David Malcom | Officer (Chief Medical Officer) | Option exercise / conversion (derivative) | 4,166 | $0.00 | $0 | Form 4 |
| 2026-05-13 | Rodman David Malcom | Officer (Chief Medical Officer) | Option exercise / conversion (derivative) | 3,541 | $0.00 | $0 | Form 4 |
| 2026-05-13 | Rodman David Malcom | Officer (Chief Medical Officer) | Open-market sale | 14,056 | $28.58 | $401.8K | Form 4 |
| 2026-05-13 | Rodman David Malcom | Officer (Chief Medical Officer) | Option exercise / conversion | 4,166 | $14.25 | $59.4K | Form 4 |
| 2026-05-13 | Rodman David Malcom | Officer (Chief Medical Officer) | Option exercise / conversion | 3,541 | $10.20 | $36.1K | Form 4 |
| 2026-05-12 | Rodman David Malcom | Officer (Chief Medical Officer) | Option exercise / conversion (derivative) | 6,348 | $0.00 | $0 | Form 4 |
| 2026-05-12 | Rodman David Malcom | Officer (Chief Medical Officer) | Open-market sale | 6,348 | $29.36 | $186.3K | Form 4 |
| 2026-05-12 | Rodman David Malcom | Officer (Chief Medical Officer) | Option exercise / conversion | 6,348 | $1.08 | $6.9K | Form 4 |
| 2026-05-11 | Rodman David Malcom | Officer (Chief Medical Officer) | Option exercise / conversion (derivative) | 2,171 | $0.00 | $0 | Form 4 |
| 2026-05-11 | Rodman David Malcom | Officer (Chief Medical Officer) | Open-market sale | 2,171 | $29.71 | $64.5K | Form 4 |
| 2026-05-11 | Rodman David Malcom | Officer (Chief Medical Officer) | Option exercise / conversion | 2,171 | $16.00 | $34.7K | Form 4 |
| 2026-04-17 | Rodman David Malcom | Officer (Chief Medical Officer) | Option exercise / conversion (derivative) | 416 | $0.00 | $0 | Form 4 |
| 2026-04-17 | Rodman David Malcom | Officer (Chief Medical Officer) | Open-market sale | 416 | $31.33 | $13.0K | Form 4 |
| 2026-04-17 | Rodman David Malcom | Officer (Chief Medical Officer) | Option exercise / conversion | 416 | $15.44 | $6.4K | Form 4 |
Ask the chat about MLYS's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: MINERALYS THERAPEUTICS INC (MLYS).
Last updated 2026-07-17 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.